# Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohnʼs disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/teduglutide-a-novel-mucosally-active-analog-of-glucagon-like-peptide-2-glp-2-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Alan L. Buchman,Seymour Katz,John C. Fang,Çharles N. Bernstein,Souheil G. Abou‐Assi |
| Citations | 143 |
| DOI | 10.1002/ibd.21117 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2162105656 |
| PMID | 19821509 |
| Type | article |
| Year | 2009 |

## Paper authors

- [John C. Fang](https://scholariq.org/researchers/john-c-fang/)

## Paper primary topic

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Paper topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Gastroesophageal reflux and treatments](https://scholariq.org/topics/gastroesophageal-reflux-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.